Generative AI Patient Education Module for Breast Oncology
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco
About this trial
This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate sites.
Eligibility criteria
Qualifiers
Females or males ages 18 and over.
Stage IV breast cancer facing a treatment change and are expected to have follow-up visits at least once every three months, or
Stage I-III breast cancer diagnosed within the past 6 months.
Basic computer literacy and regular internet access at home.
Disqualifiers
Contraindication to any study-related procedure or assessment.
Cognitive impairment that would interfere with tool usage or survey completion
Trial design
Treatments tested in this trial
- Survey (Participant)
- OpenEvidence CareConnect
- Survey (Provider)
Treatment groups
35 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov